Evidence map›Paper›PMID 42811030›Full record

ArticleNature communications2026

Dietary protein governs the role of insulin signaling in the postprandial regulation of hepatic mTORC1.

Krystle C Kalafut, Yann Cormerais, Madi Y Cissé, Samuel C Lapp, Karen E Inouye, Gökhan S Hotamışlıgil, Brendan D Manning

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Krystle C KalafutDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-3463-5533
Yann CormeraisDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-4913-0327
Madi Y CisséDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Samuel C LappDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Karen E InouyeDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Gökhan S HotamışlıgilDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-2906-1897
Brendan D ManningDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA. bmanning@hsph.harvard.edu.ORCID 0000-0003-3895-5956

Funding

U.S. Department of Health & Human Services | National Institutes of Health (NIH) F31-DK128873U.S. Department of Health & Human Services | National Institutes of Health (NIH) P01-CA120964U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35-CA197459U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32-DK128781
6 · The paper itself

Abstract

The nutrient-sensing mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway controls cellular and organismal growth and metabolism, and aberrant activation is linked to human disease, including metabolic disease. Cellular studies have established regulatory mechanisms influencing mTORC1 activation, but the physiological signals that control mTORC1 at the organismal and tissue levels are less well-defined. mTORC1 is dynamically regulated by fasting and feeding in metabolic tissues, with both nutrients and insulin proposed to activate mTORC1 in response to feeding. Here, studies employing a liver-specific genetic mouse model demonstrate that AKT-mediated TSC2 phosphorylation is the predominant mechanism of hepatic mTORC1 induction by insulin but is dispensable for activation by feeding. Furthermore, postprandial activation of hepatic mTORC1 requires dietary protein, which dictates the insulin-responsiveness of the pathway. Contrary to dogma, hepatic mTORC1 signaling was not elevated in response to diet-induced obesity, despite overt impairments in insulin and glucose homeostasis, and blocking hepatic AKT-TSC-mTORC1 signaling did not affect these metabolic phenotypes. Evidence is also provided supporting a role for glucagon in hepatic mTORC1 suppression during fasting. This study reveals a hierarchy of physiological signals regulating hepatic mTORC1.

Indexed as

Dietary ProteinsInsulinLiverMechanistic Target of Rapamycin Complex 1Postprandial PeriodAnimalsFastingGlucagonMaleMiceMice, Inbred C57BLObesityPhosphorylationProto-Oncogene Proteins c-aktSignal TransductionTuberous Sclerosis Complex 2 ProteinDietary ProteinsGlucagonInsulinMechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktTsc2 protein, mouseTuberous Sclerosis Complex 2 Protein

Identifiers

PMID42811030
PMCPMC13623872

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.